000 01055 a2200313 4500
005 20250517081347.0
264 0 _c20160614
008 201606s 0 0 eng d
022 _a1756-1833
024 7 _a10.1136/bmj.i734
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSmith, A David
245 0 0 _aDecision on folic acid fortification in Europe must consider both risks and benefits.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cFeb 2016
300 _ai734 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aDietary Supplements
_xstatistics & numerical data
650 0 4 _aFemale
650 0 4 _aFolic Acid
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aNeural Tube Defects
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
700 1 _aRefsum, Helga
700 1 _aSelhub, Jacob
700 1 _aRosenberg, Irwin H
773 0 _tBMJ (Clinical research ed.)
_gvol. 352
_gp. i734
856 4 0 _uhttps://doi.org/10.1136/bmj.i734
_zAvailable from publisher's website
999 _c25739091
_d25739091